Back to company

BORREGAARD BIOPLANT ApS: Financial statements 2025

CVR: 21500445

BORREGAARD BIOPLANT ApS (CVR 21500445) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 10,536,766 and a net result of DKK 491,045 compared with DKK 421,195 the year before. That is an increase of 1.3% compared with the year before. Equity amounted to DKK 5,520,385. The solvency ratio was 51.1%. The company had 26 employees in the financial year.

Gross Profit
10,536,766 kr.
Profit/Loss
491,045 kr.
Equity
5,520,385 kr.
Total Assets
10,808,114 kr.
Employees
26

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-10.5 mio.491 t.5.5 mio.26
2024-10.4 mio.421 t.6 mio.25
2023-9.1 mio.-754 t.5.6 mio.22
2022-10 mio.-1.5 mio.7.4 mio.21
2021-11.8 mio.900 t.9.8 mio.20

Official annual report

View the official annual report directly on the page with a Pro subscription.

Events in 2025

BORREGAARD BIOPLANT ApS: The 2024 annual report is outApr 8, 2025

BORREGAARD BIOPLANT ApS has published its annual report for 2024. Gross profit came to DKK 10,402,795, and the net result was DKK 421,195.

About BORREGAARD BIOPLANT ApS

BORREGAARD BIOPLANT ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 1999. The company is registered under the industry Ikke-specialiseret engroshandel. The management consists of Martin Lemche. The company is owned by Biobest Group NV. The company has 18 employees. In 2025, the company reported a gross profit of DKK 10,536,766 and a net result of DKK 491,045 compared with DKK 421,195 the year before. Equity amounted to DKK 5,520,385.